1) We have underpinned line‐of‐sight into Amyris’ growth:
• $900M by 2021
• 90% w/ existing customers; products already commercialized or near launch
2) We are addressing our balance sheet:
• $95M in new financing
• Over $75M reduction in debt by end 2Q
• A strong strategic partner that helps underpin financial stability for the future
3) We recognize we have a share price issue:
• 15:1 reverse stock‐split
• Enables Amyris to capitalize on strong interest from institutional investors
4) Going forward you can expect from Amyris:
• Predictable product revenue with more than 100% annual growth
• Deep focus on products where we are the lowest cost and best performing
• Continued momentum w/ partners & significant cash from Value Share Model
5) No other “shoe” to drop… Just old fashioned execution (ein echter Melo ;))
http://files.shareholder.com/downloads/...ris_Investor_Day_170516.pdf